ABMT — Advanced Biomedical Technologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Advanced Biomedical Technologies, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	2016 October 31st	2017 October 31st	2018 October 31st	2019 October 31st	2020 October 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.007	0.007	0.007	0.006	0.202
Net Total Receivables	0.02	0.017	0.033	0.05	0.029
Total Inventory
Total Current Assets	0.027	0.025	0.04	0.119	0.331
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.072	0.061	0.103	0.099	0.138
Other Long Term Assets
Total Assets	0.101	0.085	0.142	0.218	0.469
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.46	5.08	5.76	6.7	7.86
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.46	5.08	5.76	6.7	7.87
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-4.36	-5	-5.62	-6.48	-7.4
Total Liabilities & Shareholders' Equity	0.101	0.085	0.142	0.218	0.469
Total Common Shares Outstanding